Summit Therapeutics IncNASDAQ:SMMT
- LAST PRICE4.3900
- TODAY'S CHANGE (%)-0.1500 (-3.3040%)
- Bid / Lots4.3900/ 20
- Ask / Lots4.5000/ 2
- Open / Previous Close4.5200 / 4.5400
- Day Range
- 52 Week Range
- Volume1,416,219
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SMMT |
|---|---|---|
| 09:32 ET | 13276 | 4.515 |
| 09:34 ET | 4761 | 4.55 |
| 09:36 ET | 6684 | 4.61 |
| 09:38 ET | 3977 | 4.57 |
| 09:39 ET | 489 | 4.55 |
| 09:41 ET | 2395 | 4.55 |
| 09:43 ET | 2294 | 4.53 |
| 09:45 ET | 1100 | 4.5575 |
| 09:48 ET | 2396 | 4.555 |
| 09:50 ET | 3174 | 4.52 |
| 09:52 ET | 8216 | 4.49 |
| 09:54 ET | 13770 | 4.455 |
| 09:56 ET | 1520 | 4.46 |
| 09:57 ET | 3606 | 4.445 |
| 09:59 ET | 29157 | 4.4111 |
| 10:01 ET | 16483 | 4.425 |
| 10:03 ET | 7456 | 4.425 |
| 10:06 ET | 803 | 4.43 |
| 10:08 ET | 1699 | 4.45 |
| 10:10 ET | 1178 | 4.45 |
| 10:12 ET | 3811 | 4.445 |
| 10:14 ET | 400 | 4.445 |
| 10:15 ET | 587 | 4.445 |
| 10:17 ET | 300 | 4.44 |
| 10:19 ET | 3180 | 4.425 |
| 10:21 ET | 100 | 4.42 |
| 10:24 ET | 2820 | 4.42 |
| 10:26 ET | 6873 | 4.41 |
| 10:28 ET | 2738 | 4.42 |
| 10:30 ET | 100 | 4.425 |
| 10:32 ET | 25814 | 4.39 |
| 10:33 ET | 7841 | 4.445 |
| 10:35 ET | 3734 | 4.44 |
| 10:37 ET | 6418 | 4.43 |
| 10:39 ET | 1342 | 4.435 |
| 10:42 ET | 7950 | 4.425 |
| 10:44 ET | 1200 | 4.415 |
| 10:46 ET | 4426 | 4.41 |
| 10:48 ET | 3567 | 4.43 |
| 10:50 ET | 400 | 4.428 |
| 10:51 ET | 2023 | 4.43 |
| 10:53 ET | 2401 | 4.43 |
| 10:55 ET | 1700 | 4.435 |
| 10:57 ET | 2126 | 4.425 |
| 11:00 ET | 1250 | 4.415 |
| 11:02 ET | 2930 | 4.42 |
| 11:04 ET | 700 | 4.42 |
| 11:06 ET | 1640 | 4.42 |
| 11:08 ET | 10759 | 4.435 |
| 11:09 ET | 2091 | 4.435 |
| 11:11 ET | 4628 | 4.445 |
| 11:13 ET | 200 | 4.45 |
| 11:15 ET | 13685 | 4.46 |
| 11:18 ET | 12038 | 4.46 |
| 11:20 ET | 405 | 4.455 |
| 11:22 ET | 100 | 4.455 |
| 11:24 ET | 7896 | 4.44 |
| 11:26 ET | 2000 | 4.445 |
| 11:27 ET | 2219 | 4.435 |
| 11:29 ET | 2802 | 4.42 |
| 11:31 ET | 3038 | 4.42 |
| 11:33 ET | 1659 | 4.425 |
| 11:36 ET | 1256 | 4.41 |
| 11:38 ET | 500 | 4.41 |
| 11:40 ET | 1462 | 4.415 |
| 11:42 ET | 600 | 4.415 |
| 11:44 ET | 700 | 4.415 |
| 11:45 ET | 22140 | 4.38 |
| 11:47 ET | 5878 | 4.415 |
| 11:49 ET | 9350 | 4.4227 |
| 11:51 ET | 8700 | 4.4 |
| 11:54 ET | 1512 | 4.405 |
| 11:56 ET | 100 | 4.405 |
| 11:58 ET | 4599 | 4.405 |
| 12:00 ET | 100 | 4.41 |
| 12:02 ET | 10072 | 4.4 |
| 12:03 ET | 2268 | 4.3809 |
| 12:05 ET | 1995 | 4.405 |
| 12:07 ET | 1095 | 4.4 |
| 12:09 ET | 1702 | 4.395 |
| 12:12 ET | 3294 | 4.4 |
| 12:14 ET | 2811 | 4.43 |
| 12:16 ET | 300 | 4.43 |
| 12:18 ET | 200 | 4.425 |
| 12:20 ET | 1828 | 4.415 |
| 12:21 ET | 849 | 4.415 |
| 12:23 ET | 1000 | 4.405 |
| 12:25 ET | 700 | 4.4 |
| 12:27 ET | 15083 | 4.445 |
| 12:30 ET | 800 | 4.44 |
| 12:32 ET | 200 | 4.435 |
| 12:34 ET | 8978 | 4.4136 |
| 12:36 ET | 1352 | 4.405 |
| 12:38 ET | 14852 | 4.4 |
| 12:41 ET | 1870 | 4.395 |
| 12:43 ET | 1961 | 4.4 |
| 12:45 ET | 714 | 4.4 |
| 12:48 ET | 110900 | 4.38 |
| 12:50 ET | 7879 | 4.3586 |
| 12:52 ET | 4049 | 4.3547 |
| 12:54 ET | 2250 | 4.36 |
| 12:56 ET | 2814 | 4.3662 |
| 12:57 ET | 1528 | 4.365 |
| 12:59 ET | 13830 | 4.355 |
| 01:01 ET | 4709 | 4.36 |
| 01:03 ET | 2675 | 4.35 |
| 01:06 ET | 3613 | 4.37 |
| 01:08 ET | 300 | 4.36 |
| 01:10 ET | 2875 | 4.38 |
| 01:12 ET | 2003 | 4.37 |
| 01:14 ET | 1943 | 4.355 |
| 01:15 ET | 228 | 4.35 |
| 01:17 ET | 500 | 4.35 |
| 01:19 ET | 611 | 4.35 |
| 01:21 ET | 1000 | 4.355 |
| 01:24 ET | 4227 | 4.36 |
| 01:26 ET | 1469 | 4.36 |
| 01:28 ET | 3724 | 4.39 |
| 01:30 ET | 1619 | 4.4 |
| 01:32 ET | 200 | 4.4 |
| 01:33 ET | 200 | 4.405 |
| 01:35 ET | 400 | 4.405 |
| 01:37 ET | 312 | 4.4 |
| 01:39 ET | 2878 | 4.395 |
| 01:42 ET | 400 | 4.39 |
| 01:44 ET | 892 | 4.39 |
| 01:46 ET | 7982 | 4.425 |
| 01:48 ET | 2938 | 4.41 |
| 01:51 ET | 1051 | 4.415 |
| 01:53 ET | 22741 | 4.385 |
| 01:55 ET | 11587 | 4.37 |
| 01:57 ET | 2007 | 4.38 |
| 02:00 ET | 1697 | 4.39 |
| 02:02 ET | 100 | 4.39 |
| 02:04 ET | 400 | 4.39 |
| 02:06 ET | 3647 | 4.4 |
| 02:09 ET | 3400 | 4.4098 |
| 02:11 ET | 18800 | 4.41 |
| 02:15 ET | 100 | 4.405 |
| 02:18 ET | 100 | 4.41 |
| 02:20 ET | 2277 | 4.395 |
| 02:22 ET | 2920 | 4.4 |
| 02:24 ET | 800 | 4.41 |
| 02:26 ET | 300 | 4.41 |
| 02:27 ET | 400 | 4.41 |
| 02:29 ET | 2900 | 4.38 |
| 02:31 ET | 9859 | 4.42 |
| 02:33 ET | 200 | 4.41 |
| 02:38 ET | 2739 | 4.4 |
| 02:40 ET | 3020 | 4.405 |
| 02:42 ET | 100 | 4.4 |
| 02:44 ET | 3797 | 4.385 |
| 02:45 ET | 300 | 4.38 |
| 02:47 ET | 3163 | 4.385 |
| 02:49 ET | 400 | 4.385 |
| 02:51 ET | 4300 | 4.38 |
| 02:56 ET | 1300 | 4.39 |
| 02:58 ET | 500 | 4.385 |
| 03:00 ET | 6605 | 4.39 |
| 03:02 ET | 1200 | 4.41 |
| 03:03 ET | 100 | 4.41 |
| 03:05 ET | 3000 | 4.41 |
| 03:07 ET | 5588 | 4.42 |
| 03:09 ET | 3159 | 4.405 |
| 03:12 ET | 2803 | 4.405 |
| 03:14 ET | 905 | 4.405 |
| 03:16 ET | 5777 | 4.395 |
| 03:18 ET | 800 | 4.395 |
| 03:20 ET | 11719 | 4.375 |
| 03:21 ET | 6490 | 4.38 |
| 03:23 ET | 5245 | 4.395 |
| 03:25 ET | 2314 | 4.4 |
| 03:27 ET | 2769 | 4.4 |
| 03:30 ET | 6547 | 4.3802 |
| 03:32 ET | 300 | 4.38 |
| 03:34 ET | 2840 | 4.39 |
| 03:36 ET | 14635 | 4.41 |
| 03:38 ET | 2223 | 4.41 |
| 03:39 ET | 21781 | 4.4 |
| 03:41 ET | 6130 | 4.42 |
| 03:43 ET | 11194 | 4.415 |
| 03:45 ET | 8544 | 4.425 |
| 03:48 ET | 7001 | 4.415 |
| 03:50 ET | 1149 | 4.42 |
| 03:52 ET | 5638 | 4.4 |
| 03:54 ET | 18218 | 4.4 |
| 03:56 ET | 8647 | 4.405 |
| 03:57 ET | 22550 | 4.385 |
| 03:59 ET | 81166 | 4.39 |
May 7, 2024
DJ Summit Therapeutics Initiated at Buy by Citigroup, from 8:27AM ET on Tuesday May 07, 2024 by Dow Jones
8:27AM ET on Tuesday May 07, 2024 by Dow Jones
May 1, 2024
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones*DJ Summit Therapeutics 1Q Loss/Shr 6c >SMMT, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones
Apr 24, 2024
Press Release: Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:46PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:46PM ET on Wednesday Apr 24, 2024 by Dow JonesSummit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Summit Therapeutics Inc | 3.2B | -26.5x | --- |
SpringWorks Therapeutics Inc | 3.1B | -8.4x | --- |
Dyne Therapeutics Inc | 3.1B | -8.2x | --- |
Apogee Therapeutics Inc | 3.1B | -24.1x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Xenon Pharmaceuticals Inc | 3.1B | -14.4x | --- |
Company Information
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Contact Information
- Headquarters
- 2882 Sand Hill Road, Suite 106MENLO PARK, CA, United States 94025
- Phone
- 650-460-8308
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Chief Executive Officer
- Robert Duggan
- President, Co-Chief Executive Officer, Director
- Mahkam Zanganeh
- Chief Financial Officer
- Ankur Dhingra
- Lead Non-Executive Director
- Manmeet Soni
- Lead Non-Executive Independent Director
- Kenneth Clark
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.2B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 702.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.25 |
EPS | $-0.17 |
Book Value | $0.11 |
P/E Ratio | -26.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
